Headache

Real-world studies of CGRP monoclonal antibodies and gepants for migraine 5:33
Real-world studies of CGRP monoclonal antibodies and gepants for migraine
Chia-Chun Chiang • 3 Apr 2022
Neuronal complexity is reduced in chronic migraine and restored by HDAC6 inhibition 4:01
Neuronal complexity is reduced in chronic migraine and restored by HDAC6 inhibition
Amynah Pradhan • 5 Apr 2022
Telemedicine in headache care: a cohort study 3:24
Telemedicine in headache care: a cohort study
Chia-Chun Chiang • 3 Apr 2022
Elucidating the pathology of post COVID-19 headaches 3:28
Elucidating the pathology of post COVID-19 headaches
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
Recent hot-button issues in headache research at CONy 2022 2:26
Recent hot-button issues in headache research at CONy 2022
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
Upcoming trends and advances in headache treatment 1:34
Upcoming trends and advances in headache treatment
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
New treatments for migraine: who, what, and when? 4:26
New treatments for migraine: who, what, and when?
Jessica Ailani • 11 Apr 2022
How to sequence treatments in migraine 3:00
How to sequence treatments in migraine
Jessica Ailani • 11 Apr 2022
The future of oral-CGRP drugs in migraine prevention 0:47
The future of oral-CGRP drugs in migraine prevention
Sait Ashina • 17 Mar 2022
Investigating the prevalence of neck pain in migraines 2:19
Investigating the prevalence of neck pain in migraines
Sait Ashina • 17 Mar 2022
Advantages of oral anti-CGRP drugs in migraine prevention 14:28
Advantages of oral anti-CGRP drugs in migraine prevention
Sait Ashina • 17 Mar 2022
Inherited small vessel diseases: CADASIL, CARASIL, and CARASAL 2:46
Inherited small vessel diseases: CADASIL, CARASIL, and CARASAL
Antonio Federico • 27 Sep 2021
Can a headache be a warning symptom of ischemic stroke? 9:52
Can a headache be a warning symptom of ischemic stroke?
Elena Lebedeva • 7 Oct 2021
The evolutionary importance of CGRP 2:21
The evolutionary importance of CGRP
Lawrence Robbins • 23 Sep 2021
EARLY 2: erenumab in the prevention of high-frequency episodic & chronic migraine in the real world 1:56
EARLY 2: erenumab in the prevention of high-frequency episodic & chronic migraine in the real world
Piero Barbanti • 27 Sep 2021
New migraine targets: AMY1 & PACAP 1:24
New migraine targets: AMY1 & PACAP
Piero Barbanti • 27 Sep 2021
The content of VJNeurology is intended for healthcare professionals